期刊文献+

系统性红斑狼疮患者干扰素调节因子IRF1 IRF4 IRF8基因表达的研究 被引量:6

The expression of interferon-regulatory factor genes in patients with systemic lupus erythematosus
原文传递
导出
摘要 目的研究干扰素调节因子(IRF)家族中IRF1、IRF4、IRF8基因的实时定量表达水平与系统性红斑狼疮(SLE)的关联性。方法收集45例SLE患者与37名正常对照人群的临床资料,取外周血抽提总RNA并反转录为cDNA,以实时荧光定量聚合酶链反应(PCR)方法在ABI PRISM 7900 HT实时定量PCR仪上检测患者组和对照组的IRF1、IRF4、IRF8的mRNA定量表达水平(以-ΔΔCt值表示)的差异。结果正常人外周血IRF1 mRNA、IRF4 mRNA、IRF8 mRNA的表达分别是-3.90±0.19、-8.04±0.25和3.60±0.15。与正常人相比,SLE患者组IRF1 mRNA表达水平差异无统计学意义(P>0.05),而IRF4 mRNA的表达明显增高(-8.82±0.18,P=0.011)、IRF8 mRNA表达低于正常人(3.09±0.13,P=0.012)。结论SLE患者外周血存在IRF表达异常。 Objective To observe whether the expression of interferon-regulatory factor genes are related to systemic lupus erythematosus (SLE). Methods The clinical data of 45 SLE patients and 37 normal controls were collected. Total RNA of peripheral blood was extracted and transcripted into cDNA. Sybr green dye based real-time quantitative PCR method was used to compare the expression (indicated as -△△Ct value) of IRF1, IRF4, IRF8 in patients with SLE and those in the controls. Results The levels of IRF1, IRF4 and IRF8 mRNA were -3.90±0.19, -8.04±0.25 and 3.60±0.15 respectively in normal controls. In SLE patients, IRF4 mRNA expression was -8.82±0.18, higher than that in normal (P=0.011). But IRF8 mRNA expression was 3.09±0.13, lower than that in normal (P=-0.012). Conclusion Abnormal IRF mRNA expression is found in the peripheral blood of SLE patients. IRFs may play roles in the pathogenesis of SLE by affecting the differentiation of Th cells.
出处 《中华风湿病学杂志》 CAS CSCD 2006年第9期513-516,共4页 Chinese Journal of Rheumatology
基金 国家自然科学基金重点资助项目(3000154 30471613 30271224) 国家高科技研究发展计划(863计划)基金(2002AA229101) 上海市科技发展基金(01JC14029 02QMB1404) 上海市科学技术委员会科研计划基金(03DJ14009 05ZR14136) 霍英东基金会青年教师基金(81030)
关键词 红斑狼疮 系统性 聚合酶链反应 干扰素调节因子 Lupus erythematosus, systemic Polymerase chain reaction Interferon-regulatory factor
  • 相关文献

参考文献2

二级参考文献18

  • 1Mansour Al-Janadi,Suliman Al-Balla,Abdullah Al-Dalaan,Syed Raziuddin.Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases[J]. Journal of Clinical Immunology . 1993 (1)
  • 2Carter LL,Swain SL.Single cell analyses of cytokine production. Current Opinion in Immunology . 1997
  • 3Horwitz DA,Gray JD,Behrendsen SB,et al.Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis and Rheumatism . 1998
  • 4Prussin C,Metcalfe.Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. Journal of Immunological Methods . 1995
  • 5Sewell WA,North ME,David A,et al.Determination of intracellular cytokines by flow-cytometry following whole-blood culture. Journal of Immunological Methods . 1997
  • 6Lauwerys BR,Houssiaau FA.Cytokine: clues to the pathogenesis of SLE. Lupus . 1998
  • 7al-Janadi M,Raziuddin S.B cell hyperactivity is a function of T-cell-derived cytokines in systemic lupus erythematosus. The Journal of Rheumatology . 1993
  • 8Bombardier CB,Gladman DD,Urowitz MB.Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis and Rheumatism . 1992
  • 9Funauchi M,Ikoma S,Enomoto H,et al.Decreased Th1like and increased Th2-like cells in systemic lupus erythematosus. Scandinavian Journal of Rheumatology . 1998
  • 10Ogawa N,Itoh M,Goto Y.Abnormal production of B cell growth factor in patients with systemic lupus erythematosus. Clinical and Experimental Immunology . 1992

共引文献40

同被引文献61

  • 1邓筠,王元,唐元家,崔慧娟,郭彦芝,沈南.Toll样受体7及I型干扰素通路在系统性红斑狼疮中的作用研究[J].现代免疫学,2008,28(3):194-198. 被引量:10
  • 2汤建平,顾越英,沈南,钱捷,陈晓翔,黄新芳,黄向阳,梁栋,郭强,杨程德,鲍春德,陈顺乐.系统性红斑狼疮患者外周血干扰素基因的定量表达[J].中华内科杂志,2005,44(2):106-110. 被引量:8
  • 3李峰,余英豪.IgA肾病的分子生物学研究进展[J].临床肾脏病杂志,2006,6(5):237-238. 被引量:1
  • 4温成平,范永升,李永伟,李学铭.解毒祛瘀滋阴法治疗系统性红斑狼疮并发血小板减少症34例[J].中医杂志,2007,48(6):529-530. 被引量:8
  • 5Hooks JJ, Moutsopoulos HM, Geis SA, et al. Immune interferon in the circulation of patients with autoimmune disease. N Engl Med, 1979, 301: 5-8.
  • 6Bengtsson A, Sturfelt G, Truedsson L, et al. Activation of type Ⅰ interferon system in systemic lupus erythematosus correlates with disease activity but not with antlretroviral antibodies. Lupus, 2000, 9: 664-671.
  • 7Gota C, Calabrese L. Induction of clinical autoimmune disease by therapeutic interferon-alpha. Autoimmunity, 2003, 36:511-518.
  • 8Graham RR, Kyogoku C, Sigurdsson S, et al. Three functional variants of IFN regulatory factor 5 (IRFS) define risk and protective haplotypes for human lupus. PNAS, 2006,104: 6758- 6763.
  • 9Preble OT, Black RJ, Friedman RM, et al. Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science. 1982, 216: 429-431.
  • 10Suit BE, Axelred D, Moutsopoulos HM, et al. Detection of anti-interferon antibodies in systemic lupus erythematosus. Clin Exp Rheumatol, 1983, 1: 133-135.

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部